Livzon Pharmaceutical Group continues share repurchase program

Livzon Pharmaceutical Group (01513.HK) announced further share repurchase activities on April 15, 2025. The company repurchased 144,900 A-shares on the Shenzhen Stock Exchange (SZSE) for a total consideration of RMB 4,997,667, with prices ranging from RMB 34.24 to RMB 34.63 per share. Additionally, the company confirmed that 307,052,417 H-shares remain issued, with repurchased H-shares awaiting cancellation. The announcement reaffirms that the repurchases comply with listing rules and previous disclosures.